ArticleCancers2023

Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy.

Yi Tat Tong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.